Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank22
Year-over-Year Change
Enterprise value to sales ratio
Latest
0.00
↑ 100% vs avg
Percentile
P22
Within normal range
Average
-343.58
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | +100.0% |
| 2018 | -1681.70 | - |
| 2017 | 0.00 | +100.0% |
| 2016 | -1754.15 | - |
| 2015 | 0.00 | - |